News

July 29, 2020July 29, 2020

EU Approves Under-the-skin Remsima Injectable for 5 Autoimmune Disorders

News

An under-the-skin injectable formulation of Remsima (infliximab), called Remsima SC, has been approved in European Union for the treatment of five autoimmune disorders, including ankylosing spondylitis. The approval by the European ... Read more

July 20, 2020July 20, 2020

Mindfulness Linked to Reduced Fatigue-associated Disability in Arthritis

News

On days when they are more mindful or engaged in meaningful activities, people with ankylosing spondylitis or rheumatoid arthritis experience less impairment due to fatigue, a study suggests. The ... Read more

July 13, 2020July 13, 2020

Hulio, Humira Biosimilar, Approved But Not Available Until 2023

News

The U.S. Food and Drug Administration (FDA) has approved Hulio, a biosimilar of Humira (adalimumab), to treat chronic inflammatory disorders such as ankylosing spondylitis. However, Hulio (adalimumab-fkjp) — developed by Mylan and Fujifilm ... Read more

July 9, 2020July 9, 2020

National Survey Seeks to Assess Full Social, Economic Burdens of Rare Diseases in US

News, syndicated

The EveryLife Foundation for Rare Diseases has launched a nationwide National Burden of Rare Disease Survey to measure the full implications, economic and social, of living with rare disease ... Read more

July 6, 2020July 6, 2020

CHMP Favors At-home Injection Form of Remsima for Europe

News

The Committee for Medicinal Products for Human Use (CHMP), a branch of the European Medicines Agency (EMA), is recommending the use of a subcutaneous (under the skin) injection formulation ... Read more

June 23, 2020July 28, 2020

Alexion Charitable Foundation Giving $1.1M to Assist Rare Disease Community During Pandemic

News, syndicated

The Alexion Charitable Foundation has awarded $1.1 million in grants to programs that support those with rare diseases during the COVID-19 pandemic, the organization recently announced. The grants will ... Read more

June 22, 2020June 22, 2020

Simponi Effective, Including in Patients Who Tried Other TNF Blockers, Data Show

News

Simponi (golimumab) — a TNF inhibitor — is an effective therapy for people with ankylosing spondylitis (AS) and other chronic inflammatory conditions, regardless of pre-treatment with other TNF inhibitors, real-world data from ... Read more

June 18, 2020June 18, 2020

Cosentyx Approved in US to Treat Active nr-axSpA

News

Cosentyx (secukinumab) has been approved in the U.S. to treat people with active non-radiographic axial spondyloarthritis (nr-axSpA), its developer, Novartis, has announced. The approval by the U.S. Food and ... Read more

June 15, 2020June 15, 2020

Nepexto, Enbrel Biosimilar, Approved to Treat Patients in Europe

News

Nepexto, a biosimilar to Enbrel (etanercept), has been approved by the European Commission to treat ankylosing spondylitis (AS) and several other inflammatory disorders. The therapy, co-developed by Mylan and Lupin, is ... Read more

June 10, 2020June 10, 2020

Coalition Will Address Racial Disparities in Rare Disease Communities

News

The Black Women’s Health Imperative (BWHI) recently created a Rare Disease Diversity Coalition focused on reducing racial disparities in the rare disease community. Getting a timely and accurate diagnosis ... Read more

Pin It on Pinterest